Repros Therapeutics, Inc. (RPRX) Reports Q2 Loss of $0.30
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $61.06 -1.09%
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q2 EPS of ($0.30), versus ($0.20) reported last year. Revenue for the quarter came in at $1 thousand, versus $53 thousand reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
